Patent attack - The interim findings of the European Commission's pharmaceutical sector inquiry
This article was originally published in Scrip
Executive Summary
Some 10 months and 6,000 submissions later, the interim findings on competition in the EU pharmaceutical sector were unveiled at a conference in Brussels on November 28th. Initially billed by officials as "just facts and figures", the slant of the report soon became clear.